The agenda | Innovations in development for the biosimilar industry

This two day interactive conference will provide 200 key decision makers strategic and scientific knowledge in Biosimilarsand Follow-On Biologics. Leaders with scientific, business, and regulatory interests will discuss and address challenges in the development, production and launch of these complex medicines.

The primary aim is to identify key issues that will arise, and begin to solve these issues in situ.

It is an unrivalled marketing solution that will provide you with knowledge on the future of the industry, new contacts, and great exposure. The event is designed to ensure the long term health of the ecosystem, and therefore unites end users, key clients, and crucial players.

Why Attend?

  • Dig deep into the scientific foundations at the core of biosimilar development

  • Understand how to translate regulatory expectations into trial concepts with global best practice strategies in clinical trial design and execution

  • Master biosimilar manufacture, process development and scale up

  • Find out where the true biosimilar industry growth opportunities lie and what role they can play in your portfolio

  • Identify innovative tools and techniques for immunogenicity

  • Understand how to operate in the regulatory environment in Europe, Asia and America with input from key regulatory bodies

  • Gain an investor’s perspective and understand what this means for your business

  • Review recent partnering and M&A activities and the resulting impact on the biosimilar industry

  • Transform good science into a better approval process and increase patient access

  • Double your opportunities - choose to attend Biosimilars Drug Development World or the parallel World Generic Medicines Congress to learn and network with colleagues across both events


Biosimilar Drug Development 2016